Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L R Sutherland

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
The American Journal of Gastroenterology|May 16, 2000
Defining the role of fiberoptic sigmoidoscopy in the investigation of patients presenting with bright red rectal bleedingG M Van Rosendaal, L R Sutherland, M J Verhoef, et al.
Inflammatory Bowel Diseases|January 4, 2013
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials*M Campieri, H Goebell, S Hanauer, et al.
The American Journal of Gastroenterology|December 22, 1998
The utility of endoscopy in the management of patients with gastroesophageal reflux symptomsP K Blustein, P L Beck, J B Meddings, et al.
Inflammatory Bowel Diseases|March 4, 2000
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998C Gasche, J Scholmerich, J Brynskov, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2005
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's diseaseB G Feagan, W J Sandborn, J P Baker, et al.
Gastroenterology|April 21, 2001
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trialW J Sandborn, B G Feagan, S B Hanauer, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?M R Kilmurry, E J Heathcote, K Cauch-Dudek, et al.
Gastroenterology|August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study GroupW J Sandborn, W J Tremaine, D C Wolf, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
The American Journal of Gastroenterology|May 16, 2000
Defining the role of fiberoptic sigmoidoscopy in the investigation of patients presenting with bright red rectal bleedingG M Van Rosendaal, L R Sutherland, M J Verhoef, et al.
Inflammatory Bowel Diseases|January 4, 2013
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials*M Campieri, H Goebell, S Hanauer, et al.
The American Journal of Gastroenterology|December 22, 1998
The utility of endoscopy in the management of patients with gastroesophageal reflux symptomsP K Blustein, P L Beck, J B Meddings, et al.
Inflammatory Bowel Diseases|March 4, 2000
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998C Gasche, J Scholmerich, J Brynskov, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2005
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's diseaseB G Feagan, W J Sandborn, J P Baker, et al.
Gastroenterology|April 21, 2001
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trialW J Sandborn, B G Feagan, S B Hanauer, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?M R Kilmurry, E J Heathcote, K Cauch-Dudek, et al.
Gastroenterology|August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study GroupW J Sandborn, W J Tremaine, D C Wolf, et al.
Pageof 11